SightfileU.S. market data from official filings

VOR BIOPHARMA INC (VOR)

Name: VOR BIOPHARMA INC (VOR) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001817229 · EDGAR filings · Updated 2026-07-21

VOR BIOPHARMA INC (VOR) has reported institutional ownership of 82.8%, with 80 institutional managers holding positions valued at $716.9M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

82.8%

Institutional managers

Reported 13F value

$716.9M

Insider activity

81 trans.

−$61.4M net selling

Data flags

2 active

from SEC filings

Latest updates

2026-07-21 — SCHEDULE 13D/A filed
2026-07-21 — Insider transaction reported (Form 4)
2026-07-09 — Initial insider ownership filed (Form 3)
2026-07-09 — Insider transaction reported (Form 4)
2026-07-07 — Current report (8-K) filed
2026-06-12 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VOR BIOPHARMA INC has 80 institutional holders and institutional ownership of 82.8%.

Insider activity

Insiders reported 81 transactions (0 buys, 70 sells) across 11 reporting insiders, with a net reported value of −$61.4M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2025-08-12 (recurring since 2024-08-08) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-04-25 (recurring since 2024-08-30) — source filing. The authoritative details are those stated in the filing itself.

Related companies

GERON CORP (GERN) · IRADIMED CORP (IRMD) · SOLID BIOSCIENCES INC (SLDB) · JADE BIOSCIENCES INC (JBIO) · LB PHARMACEUTICALS INC (LBRX) · KURA ONCOLOGY INC COM (KURA)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.